insights_auto
Perspektīva: 40.0% garā pozīcija·0.0% īsā pozīcija
Pāriet uz analīzichevron_right
M1CK34:BVMF
Mckesson Corp Bdr
71,19 R$
0,00%
(0,00) 1 d.
7. okt., 16:37:42 GMT-3 · BRL
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: M1CK34…
Tirgus kapitalizācija
106,98 mljrd.
Vid. apjoms
297,00
Apjoms
0,00
Augstākā 52 ned.
81,67 R$
Zemākā 52 ned.
55,63 R$
Apgrozībā esošās akcijas
116,59 milj.
Darbinieku skaits
42 tūkst.
Tirgus kapitalizācija
106,98 mljrd.
Vid. apjoms
297,00
Apjoms
0,00
Augstākā 52 ned.
81,67 R$
Zemākā 52 ned.
55,63 R$
Apgrozībā esošās akcijas
116,59 milj.
Darbinieku skaits
42 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Yahoo Finance Singapore
·
pirms 49 minūtēm
How AI Adoption Could Supercharge McKesson (MCK)
AD HOC NEWS
·
pirms 59 minūtēm
Barclays raised its target for McKesson stock to USD 1,000.00
Stocktwits
·
pirms 11 stundām
OPCH Stock Soars 22% After-Hours On $5B McKesson Buyout Talks
MarketWatch
·
pirms 17 stundām
McKesson Corp. stock underperforms Wednesday when compared to competitors
Profils
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
Par “Mckesson Corp Bdr”
ĢenerāldirektorsBrian S. Tyler
Darbinieki42,3 tūkst.
Dibināšanas datums1835
Galvenais birojs-
SektorsHealth care provider
Tīmekļa vietnemckesson.com